Acute lower respiratory tract infections have mainly become a secondary diagnosis in 2022 in hospitalized COVID-19 cases in Germany

Als Co-Autor mit Prof. Gün­ter Kampf

In 2020 and 2021, 56.2% of hos­pi­ta­li­zed COVID-19 cases in Ger­ma­ny were cate­go­ri­zed with the prin­ci­pal dia­gno­sis of an acu­te lower respi­ra­to­ry tract infec­tion. In the mean­ti­me, howe­ver, appro­xi­m­ate­ly 95% of the Ger­man popu­la­ti­on have IgG anti­bo­dies against the S‑antigen. At the same time, the omic­ron vari­ant of SARS-CoV‑2 beca­me domi­nant with a lower patho­ge­ni­ci­ty resul­ting in a redu­ced risk for inten­si­ve care tre­at­ment and mecha­ni­cal ven­ti­la­ti­on. Both deve­lo­p­ments may result in a lower bur­den of acu­te respi­ra­to­ry tract infec­tion among hos­pi­ta­li­zed COVID-19 cases. That is why we ana­ly­zed the renu­me­ra­ti­on data of the natio­nal health insu­ran­ces in Ger­ma­ny (Janu­ary 2020–September 2022) pro­vi­ded by the Insti­tu­te for the Hos­pi­tal Renu­me­ra­ti­on System.

Wei­ter­le­sen in Infec­tion

Anmer­kung: Die Inhal­te die­ses Bei­trags wur­den zuvor in einem Bei­trag auf Mul­ti­po­lar veröffentlicht.

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert